Could a virtual board help doctors tackle prostate cancer genetics?

NCT ID NCT04789018

Ongoing Knowledge-focused Sponsor: Thomas Jefferson University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether a web-based virtual genetics board helps doctors discuss and manage prostate cancer genetics. About 118 healthcare providers, including oncologists and genetic counselors, will use the board and then give feedback through surveys and interviews. The goal is to see if the tool is useful and easy to use, not to directly treat patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Educational intervention (virtual genetics board)
What this could lead to: If successful, this could lead to a tool that helps doctors better use genetic information to treat and screen for prostate cancer.
What could go wrong: This is a small, early-stage study focused on provider opinions, not patient outcomes. The tool may not prove useful or practical in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer prostate carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CARCINOMA

Contacts and locations

Show contact details

Locations

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Philadelphia, Pennsylvania, 19107, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.